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Associating transcription factors 
and conserved RNA structures with 
gene regulation in the human brain
Nikolai Hecker1,2,3,7, Stefan E. Seemann1,2, Asli Silahtaroglu  1,4, Walter L. Ruzzo1,5,6 &  
Jan Gorodkin1,2
Anatomical subdivisions of the human brain can be associated with different neuronal functions. This 
functional diversification is reflected by differences in gene expression. By analyzing post-mortem gene 
expression data from the Allen Brain Atlas, we investigated the impact of transcription factors (TF) and 
RNA secondary structures on the regulation of gene expression in the human brain. First, we modeled 
the expression of a gene as a linear combination of the expression of TFs. We devised an approach to 
select robust TF-gene interactions and to determine localized contributions to gene expression of TFs. 
Among the TFs with the most localized contributions, we identified EZH2 in the cerebellum, NR3C1 
in the cerebral cortex and SRF in the basal forebrain. Our results suggest that EZH2 is involved in 
regulating ZIC2 and SHANK1 which have been linked to neurological diseases such as autism spectrum 
disorder. Second, we associated enriched regulatory elements inside differentially expressed mRNAs 
with RNA secondary structure motifs. We found a group of purine-uracil repeat RNA secondary 
structure motifs plus other motifs in neuron related genes such as ACSL4 and ERLIN2.
Transcription factors (TF) and regulatory elements (RE) located in mRNAs are among the most fundamental 
features for governing the expression of genes, and thereby the function and fate of a cell. Transcription factors 
and different co-factors often form large protein-complexes that regulate the transcription1. Post-transcriptional 
regulation is achieved by a similar combinatorial complexity of RNA binding proteins (RBP) and protein-protein 
interactions2. Common principles include stabilizing mRNAs or enhancing their degradation, as well as mod-
ifying transcripts, e.g., by splicing or alternative poly adenylation (APA)3. With the advent of high-throughput 
cross-linking and immuno-precipitation sequencing (CLIP-seq) and RNA immuno-precipitation sequencing 
(RIP-seq) technologies, experiments have been performed with the aim to characterize RBP complexes and their 
RNA targets including more than 1000 RBPs4.
The human brain is a prime candidate for studying both transcriptional and post-transcriptional regulation 
due to its complex functional sub-divisions5. Although many processes in the brain rely on an interplay between 
interconnected processing modules, some areas appear to be of special importance for certain functions inside 
the central nervous system (CNS). For example, the cerebellum was traditionally associated with motor control 
whereas the parietal and frontal lobe inside the cerebral cortex are often associated with more abstract processes 
such as short-term and long-term memory6–8. For some brain regions, there is an apparent difference in the 
cyto-architecture. For instance, the ratio between non-neuron cells and neuron cells is ≈3.76 inside the human 
cerebral cortex compared with ≈0.23 inside cerebellum9. The function and differentiation of a cell such as a 
neuron is dictated by the regulation of gene expression. Hence, studying gene expression inside the brain has 
been recognized as an important part of neuroscience. The Allen Institute for Brain Science created an extensive 
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resource of gene expression data sets that cover a wide-range of human and mouse brain regions10. Hawrylycz et 
al. identified gene expression modules that correspond to distinct cell types and assessed overall differences in 
gene expression inside the human brain11. However, there has not been a systematic analysis that addresses the 
underlying features that govern gene expression inside the different regions of the human brain. Therefore, we 
analyzed micro array data from the Allen Brain Atlas10 with the aim to identify transcription factors and regu-
latory elements inside mRNAs that are important for gene expression in the brain, especially ones characteristic 
for specific brain regions.
In line with existing studies that aim to predict transcription factor (TF) interactions, we analyzed Chromatin 
immuno-precipitation sequencing (ChIP-seq) and gene expression data using a regression approach12, 13. In this 
study, we used ENCODE ChIP-seq data from the UCSC Genome Browser14–17. A more recent study suggested 
that combining gene expression data from TF perturbation experiments, e.g., over-expression or knock-down 
of TFs, with LASSO regression exhibits more accurate results than approaches based on TF binding affinities18. 
However, generating such TF perturbation gene expression data requires performing extensive experiments that 
are limited to cell lines and model organisms. Hence, it is not applicable to the large brain region post-mortem 
data set analyzed in our study. On the other hand, the ENCODE ChIP-seq data, used in this study, is not specific 
to the different brain regions. Therefore, we cannot infer read counts directly; instead, we focus on the most 
robust TF-gene interactions. For this purpose, we select the best-scoring ENCODE ChIP-seq peak cluster to infer 
potential TF-gene interactions and apply a more rigorous treatment of regression models. Our approach uses 
LASSO regression to select the most relevant set of interactions for each TF19 and then compares linear models 
derived from the set of selected interactions to random models. Brain region specific TF activity is one of the 
major mechanisms that regulates differences in gene expression, thus functional diversity in the brain. We devised 
an approach to assess the localization of the contribution to gene expression of a specific TF given different brain 
regions. In this context, we derive the contribution of a TF to gene expression from the regression coefficients, 
thereby quantifying the impact of a TF rather than its expression. This allows one to identify the TFs with the 
highest impact in a region, and to identify TFs with localized contributions to specific regions. We use Shannon 
entropy for identifying region-specific TF contributions, i.e., localized contributions, as previous studies have 
done to analyze region specific gene expression20.
Regulatory elements within mRNAs are another fundamental feature of gene regulation. Although there are 
some regulatory elements in mRNAs that form RNA structures, e.g., the roquin constitutive decay element21, 
regulatory RNA structures are less well characterized in general. In a previous study, our predictions showed 
that expressed protein-coding genes in mouse brains are enriched for the presence of conserved RNA secondary 
structures in their UTRs22. Therefore, here, we also aim to identify novel RNA secondary structure motifs that 
are potentially relevant for post-transcriptional regulation of transcripts in the human brain. Several computa-
tional approaches and studies have aimed to link gene expression data, RBP binding or decay rates with RNA 
secondary structure predictions23–26. An elaborate systematic study of sequence or structure based binding affin-
ities of RBPs was performed on 30 mer RNA sequences that reflect eukaryotic transcriptomes27. A limitation of 
these existing approaches is, however, the lack of evolutionary evidence for the predicted RNA secondary struc-
tures. Comparative approaches for RNA secondary structure prediction have a lower false discovery rate than 
single-sequence based methods28, 29. In this study, we put an emphasis on cis-regulatory elements (RE) that are 
annotated in the AURA database30 and overlap with predicted conserved RNA secondary structures. For exam-
ple, these REs include RNA protein binding sites and AU-rich elements. We refer to REs that overlap RNA sec-
ondary structure predictions as structured REs. The inferred structure predictions originate from a genome-wide 
computational screen for conserved RNA structures in vertebrate genome-alignments31.
Results
Throughout this manuscript, we consider six different levels of coarse-graining for separating brain regions fol-
lowing the ontology as specified by the Allen Human Brain Atlas (Supplementary file S1, Fig. S1)10. We refer to 
these different levels of coarse-graining as depths where depth 1 refers to the entire gray matter of the brain. At 
depth 2, we are analyzing the telencephalon (Tel) also known as the cerebrum, diencephalon (DiE), metencepha-
lon (MET), mesencephalon (MES) and myencephalon (MY). Depth 3 contains sub-regions of these five regions, 
e.g., the cerebral Cortex (Cx) and cerebral Nuclei (CxN) as sub-regions of the telencephalon. In the following sec-
tion, we limited the results to robust findings, specifically, findings that could be reproduced in five independent 
instances of the analysis. Each instance of the analysis was initialized with different seeds for the random number 
generator, thus using different training or test sets during randomization steps.
Transcription factor contribution to gene expression. Based on a regression approach (see Material 
and Methods), we predicted eleven TFs with robust strong contributions to gene expression throughout all ana-
lyzed regions of depth 2, 3 and 4 (Fig. 1, Table 1) and three TFs with strong localized contributions to specific 
brain regions. This was done by modeling the expression of a gene as a linear combination of the expression of 
transcription factors. Since we used LASSO regression, the set of TFs is reduced to TFs that show a relevant con-
tribution to the expression of the gene. The resulting coefficients of the linear models are then used to estimate the 
contribution of each transcription factor to the expression of the gene. To increase the robustness of our results, 
we compared the resulting linear models to random models and only considered models that performed better 
than the random models (Supplementary text S1, Fig. S3). We refer to the corresponding genes as TF regulated 
genes. Given the linear models, a gene is usually predicted to be regulated by more than one TF. For simplicity, 
we write that a TF regulates a gene if it is robustly predicted to be involved in the regulation of the gene. The 
contribution to gene expression of a TF inside a brain region is calculated as the sum over the contributions to 
the expression of all TF regulated genes. From the linear models, we also extracted the genes that were predicted 
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to be regulated by a specific TF (Supplementary file S4) and computed the enrichment for GO-term using the 
ConsensusPathDB32 as described below.
Brain-wide most active transcription factors. First, we aimed to characterize the most active TFs throughout 
the brain, i.e., the TFs that were predicted to show the highest contributions in all analyzed brain regions. Eleven 
TFs ranked among the top 20 out 141 TFs regarding the highest contribution to gene expression in each region 
Figure 1. Transcription factor contributions to gene expression. The color gradient indicates the contribution 
to gene expression and is capped between 5% and 95% quantiles for all transcription factors (rows) in 
all depicted region (columns). Cx refers cerebral cortex, CxN to cerebral nuclei, TH to thalamus, Hy to 
hypothalamus, Cb to cerebellum and MTg to mid-brain tegmentum. Depicted are the contributions of the 25 
transcription factors with the strongest contribution in any of the regions at depth 3 from one instance out of a 
five-times repeated analysis. Arrows point to transcription factors with localized contributions (bold font). Italic 
font indicates transcription factor with comparably strong contributions to gene expression in all regions and all 
instances of the analysis including different region hierarchy depths.
TF rmax Tel MET Cx Cb BF Tsel nrobust Tsel:
MAX 2 149.86 48.49 110.93 61.87 31.22 Tel 180
TAF1 5 64.96 30.47 45.91 42.36 10.57 Tel 101
YY1 9 59.05 23.72 59.57 19.39 13.65 Tel 90
POLR2A 11 88.05 23.94 76.97 52.09 12.82 Tel 252
CEBPB 12 30.99 86.87 25.25 36.43 12.23 MET 64
JUND 14 35.75 17.39 41.50 21.93 13.47 Tel 34
NFYB 14 30.53 12.19 24.15 21.35 16.73 Tel 52
REST 14 38.72 47.50 21.51 25.24 9.5 MET 39
GABPA 15 49.29 26.25 41.12 52.55 18.06 Tel 101
TCF12 17 24.99 20.16 19.65 18.06 3.33 Tel 25
SP1 18 27.89 11.52 17.05 15.68 6.77 Tel 54
EZH2 81 3.42 19.02 2.83 19.62 1.47 MET 11
NR3C1 40 32.39 26.20 33.00 22.60 3.55 Cx 20
SRF 95 2.24 0.88 0.94 1.19 10.57 BF 5
Table 1. Transcription factor contributions to gene expression and the number of regulated genes. 
Transcription factors (TF) with the strongest contribution to gene expression (ranked ≥20 in all regions) are 
given in the upper part and TFs with localized contributions are shown in the lower part of the table. rmax is the 
maximum (worst) rank in any region for the TF. Tel (telencephalon), MET (metencephalon), Cx (cerebral 
cortex), Cb (cerebellum) and BF (basal forebrain) show the contribution to gene expression of the TF in the 
specified region. These values are averages over five runs of the analysis initialized with different seed for the 
random number generator. Tsel indicates the region with the highest contribution to gene expression at depth 2 
for brain-wide active TFs and a selected region with localized contributions for locally active TFS. nrobust T: sel refers to the number of TF-gene interactions that were consistently predicted in these five runs for the 
correspoding region.
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of depth 2, 3 and 4 (Supplementary text S1, Figs S4–S18). Although the eleven TFs exhibit strong contribu-
tions to gene expression in all analyzed regions, the strongest contributions were in general either predicted 
for the telencephalon or metencephalon (Table 1, Supplementary file S3). The TF MYC associated factor X 
(MAX) showed the strongest contribution to gene expression overall in the analyzed brain regions. MAX reg-
ulates 180 genes inside the telencephalon. These 180 genes are enriched for the GO-terms primary metabolic 
process (GO:0034660)(q-value < 0.05), as well as nucleoplasm, intracellular organelle part, nucleus, heterocyclic 
compound binding, organic cyclic compound binding, transferase activity and nucleic acid binding chromatin 
binding (q-value < 0.005) (Supplementary file S5). Other globally active TFs regulate genes that are enriched for 
similar GO-terms, i.e., the TF TATA-box binding protein associated factor 1 (TAF1), YY1 transcription factor 
(YY1), RNA polymerase II subunit A (POLR2A), and GA binding protein transcription factor alpha subunit 
(GABPA) (Supplementary file S5).
Also predicted to be among the globally most active TFs, CCAAT/enhancer binding protein beta (CEBPB), 
RE1 silencing transcription factor (REST) and Sp1 transcription factor (SP1) regulate more exclusively genes 
with neuronal function. CEBPB regulates the microtubule associated genes (GO:0097427) microtubule affinity 
regulating kinase 2 (MARK2) and microtubule cross-linking factor 1 (MTCL1 also known as SOGA2), and three 
steroid hormone receptor activity related genes (GO:0003707), i.e., nuclear receptor subfamily 2 group F member 
6 (NR2F6), retinoic acid receptor beta (RARB) and nuclear receptor subfamily 1 group D member 2 (NR1D2) 
inside the telencephalon. A functional circuit involved in intraciliary transport (GO:0030990) comprises the 
proteins TULP3, IFT20 and IFT27, and is predicted to be commonly regulated by the TF SP1 among other genes.
REST is predicted to regulate 59 genes inside the telencephalon. The genes predicted to be regulated by 
REST are enriched for neuron related GO-terms (q-value < 0.05) of which 14 of the 59 genes are members, 
e.g., somatodendritic compartment (GO:0036477), neuron projection (GO:0043005) and calcium ion binding 
(GO:0005509) (Supplementary file S5). These 14 neuron related genes are: bone morphogenetic protein receptor 
type 1B (BMPR1B), C2 calcium dependent domain containing 4A (C2CD4A), cyclin dependent kinase 5 regu-
latory subunit 1 (CDK5R1), contactin associated protein 1 (CNTNAP1), G protein subunit alpha o1 (GNAO1), 
glutamate ionotropic receptor NMDA type subunit 1 (GRIN1), potassium voltage-gated channel subfamily C 
member 1 (KCNC1), NSF attachment protein alpha (NAPA), neurocan (NCAN), RNA polymerase II subunit M 
(POLR2M), protein kinase C substrate 80K-H (PRKCSH), solute carrier family 12 member 5 (SLC12A5), sushi, 
nidogen and EGF like domains 1 (SNED1) and tumor protein D52 (TPD52). Although not significantly enriched 
(q-value = 0.06), four REST regulated genes include members of the BDNF pathway, i.e., mitogen-activated pro-
tein kinase 8 (MAPK8), GRIN1, CDK5R1 and early growth response 2 (EGR2).
Based on our predictions, the TFs showing the highest contributions to gene expression throughout the brain, 
e.g., MAX and YY1, are involved in regulation of processes common to several cell types including metabolic 
processes. These results agree with the wide range of functions of MAX which have been suggested in previous 
studies33. Our approach predicted MAX as the most influential regulator in the brain. Our analysis also identified 
TFs regulating primarily neuronal processes such as REST. REST is considered to be the master negative regulator 
of neurogenesis34, 35.
Localized transcription factor contributions. Since different brain regions have different functions, an interesting 
aspect related to these functions is whether some TFs show brain region specific contributions, i.e., pronounced 
localized contributions. Similarly to region specific gene expression20, this tendency can be assessed by Shannon 
entropy for the contribution of a specific TF over the regions of the same depth (see Methods: Regression analysis 
of transcription factor interactions). Here, a highly region specific contribution is indicated by a low entropy 
whereas a high entropy indicates more evenly distributed contributions over all regions in a given brain hierarchy 
depth. TFs with a strong localized contribution should be characterized by a high contribution to gene expression 
in a region and a low entropy. We identified three TFs with strong and robust local regulatory signatures char-
acterized by a high contribution to gene expression in one brain region and a low entropy. These TFs were in the 
top 1/3 quantile for the contribution in a brain region and the top 1/3 quantile for the lowest entropy over brain 
regions of the same depth.
Based on our results, the Enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) showed the 
most localized contributions to the metencephalon and specifically to the cerebellum (Fig. 1). Our analysis sug-
gests that EZH2 is involved in the regulation of 39 and 30 genes inside the metencephalon and its anatomical 
sub-region the cerebellum, respectively (Supplementary file S4). Eleven of these genes are predicted to be reg-
ulated by EZH2 in both the metencephalon and cerebellum. These eleven genes include Zic family member 2 
(ZIC2) and SH3 and multiple ankyrin repeat domains (SHANK1). ZIC2 and SHANK1 are associated with nerv-
ous system development (GO-term GO:0007399). In addition, inside the cerebellum, six EZH2 regulated genes 
are related to neuronal processes (Supplementary file S5) including neuronal differentiation 2 (NEUROD2) and 
somatostatin receptor 2 (SSTR2) which are both part of the GO-terms cerebellum development (GO:0021549) 
and metencephalon development (GO:0022037) (Supplementary file S5). Similarly, seven additional EZH2 reg-
ulated genes inside the metencephalon are related to neuronal processes. For instance, our model predicted that 
EZH2 regulates neuronal PAS domain protein 3 (NPAS3).
The Nuclear receptor subfamily 3 group C member 1 (NR3C1) exhibits its most localized contributions to 
gene expression inside cerebral cortex (Fig. 1). In the cerebral cortex, NR3C1 is involved in the regulation of 
20 genes including the ephrin receptor binding associated genes (GO:0046875) ephrin A5 (EFNA5) and cyclin 
dependent kinase 5 regulatory subunit 1 (CDK5R1). Both, CDK5R1 and EFNA5 are also associated with the reg-
ulation of microtubule cytoskeleton organization (GO:0070507) (Supplementary file S5). The majority of NR3C1 
regulated genes (14 of the 20) are nucleus-specific (GO:0005634). The second largest contribution of NR3C1 to 
gene expression is inside the cerebellum (Fig. 1) where NR3C1 is involved regulating EFNA5 and CDK5R1, too.
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For the serum response factor (SRF), we predicted a localized contribution to gene expression in the Basal 
forebrain (BF) (Supplementary file S2 and 3, Supplementary file S1, Figs S14–S18). Here, SRF contributes to 
the regulation of two F-box genes, F-box and leucine rich repeat protein 16 (FBXL16), and F-box protein 46 
(FBXO46), SERTA domain containing 1 (SERTAD1), DEAD-box helicase 51 (DDX51) and RAB40B, member 
RAS oncogene family (RAB40B).
The three TFs with the most localized contributions, based on our analysis, EZH2, SRF and NR3C1 are 
known regulators in different contexts: EZH2 in epigenetic regulation36, SRF as regulator of the cytoskeleton37 
and NR3C1 in relation to prenatal stress exposure38. Our results suggest additional functions of EZH2, SRF and 
NR3C1 in specific neuroanatomical regions.
Regulatory elements of differentially expressed mRNAs. In addition to the analysis of TFs’ 
contribution to gene expression, we aimed to identify elements of mRNAs that are potentially important for 
post-transcriptional regulation. For this purpose, we analyzed differential gene expression between all pairs of 
sub-regions within nine different brain regions. Our assumption is that regulatory features in mRNAs which 
influence gene expression should contribute to a differential expression of the mRNAs that they are part of. In 
other words, for mRNAs that are not differentially expressed, there is no indication that they contain regulatory 
elements that influence their gene expression.
To address this, we analyzed regions that consist of two to five sub-regions (Supplementary file S1, Fig. S1). For 
regions that contained more than two sub-regions, we performed all pair-wise comparisons between sub-regions 
and combined all genes that were significantly differentially expressed. Differential expression analysis was per-
formed using the limma package and a log-fold change of log2 1.5 (see Methods)39. The number of genes that 
were expressed above background in each region was between 16,308 and 16,959 genes (see Methods). For the 
most coarse-grained level of analyzed brain regions, i.e., grey matter, we found 11,176 significantly differentially 
expressed genes (Fig. 2A). Similarly, there was a high number of differentially expressed genes between the cere-
bellum and pons inside the metencephalon, i.e., 10,261 most-likely due to a different cyto-architecture. Notably, 
only 5 and 22 genes were found to be differentially expressed inside the cerebellar hemispheres and parietal lobe 
of the cerebral cortex, respectively.
Enrichment of regulatory elements. For identifying Regulatory Elements (RE) of mRNAs that potentially con-
tribute to the differential gene expression in the human brain, we computed enrichment of annotated REs located 
in differentially expressed genes (Supplementary file S1, Fig. S2). We considered annotated REs from the AURA 
database which groups REs into distinct types such as AU-rich elements (ARE), hyper-conserved elements 
(HCE), miRNA target sites (miRNA), RNA binding proteins binding sites (RBP) and alternative poly-adenylation 
sites (APA)30. As a prerequisite for identifying potentially regulatory RNA secondary structure motifs, we identi-
fied enriched REs that overlap with predictions for conserved RNA secondary structures. We inferred the predic-
tions from a genome-wide screen for vertebrate-conserved RNA secondary structures (CRS) using CMfinder31 
and computed the overlap with annotated REs from the AURA database30. We considered REs and structure pre-
dictions as overlapping if at least one nucleotide of an annotated RE overlaps with the genomic coordinates of the 
structure prediction. For simplicity, we refer to annotated REs that overlap RNA secondary structure predictions 
as structured REs. Differentially expressed mRNAs were considered to be enriched for types of REs or specific 
REs such as RBM47 binding sites if a χ2-test resulted in a Benjamini-Hochberg adjusted p-value < 0.05 and at 
least ten different differentially expressed genes contained the RE.
In total, the binding sites of 55 RBPs and of 31 miRNAs were enriched in differentially expressed genes in at 
least one of the analyzed brain regions. In particular, structured binding sites of 32 distinct RBPs were enriched 
in differentially expressed genes (Supplementary file S6). However, for most cases, the binding sites of specific 
RBPs were also enriched when ignoring the REs overlap with RNA secondary structure predictions. We found 
an enrichment for structured AREs for all regions except the cerebral cortex, parietal lobe, limbic lobe and the 
cerebellar hemispheres (Fig. 2B). As expected by the difference in UTR lengths, fewer types of structured REs are 
enriched in 5′-UTRs compared with REs in 3′-UTRs (Supplementary file S1, Fig. S19). There is an enrichment for 
structured RBP binding sites inside 5′-UTRs of differentially expressed genes inside grey matter in general, the 
telencephalon, metencephalon and the limbic lobe.
Re-occurrence of structured regulatory elements. Our main aim in this part of the analysis is to categorize com-
mon RNA secondary structure motifs for enriched structured REs. The differentially expressed genes within any 
sub-region of the human brain comprise 11,363 conserved RNA secondary structures (CRS) corresponding to 
enriched structured REs. We searched for additional instances of the CRSs in the human genome (see Methods: 
Structure motif re-occurrence) by similarity of CRSs using Infernal CMsearch40. We identified 65 CRSs with reoc-
curring instances within REs of the same category in at least three different genes (see Methods: Structure motif 
re-occurrence). The same category refers to a specific entity of structured REs that is enriched for differentially 
expressed genes inside a specific region, e.g., ARE or RBP, or more specific RBP binding sites like RBM47 binding 
sites of differentially expressed genes inside grey matter. We required that at least 90% of the base pairs of the 
consensus RNA structure of a CRS were predicted for the target sequence and that the sequence did not overlap 
repeats except simple repeats based on RepeatMasker annotations from the UCSC Genome Browser17.
We further selected 15 high quality CRSs (Supplementary file S1, Figs S21–S24, Table S5,41) by filtering for 
evolutionary conservation of base pairs (normalized parsimony scores higher than median), neither extreme GC 
content (between 0.2–0.8) nor pair-wise sequence identity (<0.95). The evolutionary conservation of base pairs 
was assessed by computing parsimony scores that describe how consistently base pairs were inherited or lost 
inside a phylogenetic subtree (see Methods: Analysis of RNA secondary structure motifs).
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We assessed the similarity of motifs corresponding to two CRS by evaluating for which sequences of struc-
tured REs they were predicted (Fig. 3). The overlap between the sequences of predicted instances was then used 
to compute a similarity score between 0 and 1. Sequences with predicted instances of motifs corresponding to 13 
out of the 15 CRS overlap with at least one other of the 15 CRS. All 13 of these motifs contain purine-uracil tan-
dem repeats ((RU)n repeats). Eight of these 13 motifs form a cluster of relatively AU-rich sequences (GC content 
<0.3). Instances of these (RU)n repeat motifs were predicted for several REs of neuron related genes including 
neuron projection associated genes (Supplementary file S7): acyl-CoA synthetase long-chain family member 4 
(ACSL4), plexin A1 (PLXNA1), tetraspanin 2 (TSPAN2), Ras associated (RalGDS/AF-6) and pleckstrin homol-
ogy domains 1 (RAPH1) (Fig. 4A), and potassium voltage-gated channel subfamily H member 5 (KCNCH5). 
See ‘Supplementary text S1 - Instances of RNA secondary structure motifs’ for additional information about CRS 
instances in specific genes.
The two remaining CRS motifs, which do not overlap with the other thirteen motifs, were each found in RBP 
binding sites of three different genes that were differentially expressed in gray matter and in the case of CRS motif 
M1146447 also differentially expressed inside the metencephalon ((Fig. 4B, Supplementary text S1, Figs S2 and 
3C). Instances of CRS motif M1146447 were predicted in the 3′-UTRs of ER lipid raft associated 2 (ERLIN2), 
FK506 binding protein 5 (FKBP5) and sphingosine kinase 2 (SPHK2).
Figure 2. Enriched structured regulatory elements in differentially expressed genes. (A) The number of 
differentially expressed genes between any two sub-regions of the indicated region. (B) Enriched regulatory 
elements for the set of differentially expressed genes. RE refers to regulatory elements. If a RE overlaps with a 
RNA secondary structure predictions it is referred to as structured RE.
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In summary, we identified a family of (RU)n-repeat RNA structure motifs and two additional structure motifs 
that occurred in several structured REs inside UTRs of differentially expressed genes in the brain including genes 
associated with neurons such as ACSL4, PLXNA1 and KCNCH5.
Discussion
Using post-mortem gene expression data of human brains and non-brain specific ChIP-seq data, we identified 
the most active transcription factors (TF) in the brain and transcription factor contributions to gene expression 
that are localized to the metencephalon, cerebellum, cerebral cortex and Basal forebrain. In addition, we used 
known regulatory elements (RE) in the UTRs of mRNAs that were enriched for differentially expressed mRNAs 
in the brain as a starting point for finding novel RNA secondary structure motifs with potential relevance for 
post-transcriptional regulation.
Our results suggest that the transcription factors with the highest contributions to gene expression in all brain 
regions, i.e., MAX, TAF1, POLR2A, GABPA and YY1, contribute to regulating genes that are involved in more 
general cellular processes such as metabolic processes and secondary transcription factor activity given an enrich-
ment for GO-terms such as nucleus and nucleic acid and chromatin binding. However, our analysis also suggests 
CNS and neuron related TF-gene interactions. MAX is known to interact with v-myc avian myelocytosis viral 
oncogene homolog (MYC), but MAX also dimerizes with several other proteins such as MAD33. Supporting our 
predictions, MAX is known to regulate genes related to cellular growth, proliferation, differentiation and metabo-
lism. MAX is mainly active in the brain, heart and lungs42. For REST, we predicted the most obvious involvement 
in the regulation of neuron related genes including down-regulation of voltage-gated potassium channel KCNC1 
and NMDA type receptor GRIN1. These results agree with observations from previous studies34, 35. REST is a 
strong repressor of neuronal gene transcription in non-neuronal cells. REST is considered to be the master nega-
tive regulator of neurogenesis. REST functions by binding to Neuron-restrictive silencer elements (NRSE) in the 
DNA which was identified in stem cells and different types of mature neurons. REST has been suggested to play a 
role in the maintenance of neuronal phenotype. REST represses genes that promote cell death in the brain and is 
shown to be lost in the brain in Alzheimer’s and dementia patients43, 44.
Although not exclusively CNS related, genes regulated by the TFs GABPA, TAF1, YY1 and POLR2A also 
show an enrichment for GO-terms related to localization and transport (Supplementary file S5), which might be 
of special relevance for neurons. CEBPB and SP1, also among the 20 TFs with the highest contributions to gene 
expression in all brain regions, exhibit a less diverse contribution to gene expression. Potentially related to trans-
port in neurons, CEBPB contributes to regulation of microtubule associated genes MARK1 and MTCL1 based 
on our analysis. In vivo knock down of Mtcl1 in the cerebellum results in loss of axonal polarity in Purkinje cells. 
Dis-function of the gene leads to spinocerebellar ataxia. MARK1 is suggested as an autism susceptibility gene 
after a SNP analysis in 276 families45, 46. Our results indicate an involvement of SP1 in the regulation of intraciliary 
Figure 3. Overlap between predicted instances of reoccurring RNA structure motifs. The overlap between the 
predicted instances is depicted for 15 CRS motifs. The 15 CRSs are well conserved and predicted inside enriched 
structured regulatory elements for at least three different differentially expressed genes. The overlap between 
instances a CRS motif A and instances of a CRS motif B is computed by = ∩| |
| | | |
overlap A B
A Bmax{ , }
. The heatmap 
shows a single-linkage hierarchical clustering between the CRS motifs.
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transport particle related genes ITF20, ITF27 and TULP3. The importance of the primary cilia in the human 
brain and its relation to neurological disorders has been discussed more recently47. Germline homozygote Tulp3 
mutation resulted in death of the E14.5 day fetal mouse with defects in the hindbrain and neuronal tube48. Hence, 
the regulation of ITF20, ITF27 and TULP3 by SP1 are interesting candidate interactions for further investigation 
in the brain.
EZH2 showed the most localized contributions to gene expression to specific brain regions of the top three 
TFs, i.e., EZH2, NR3C1 and SRF. EZH2 is a member of polycomb group of genes that functions in the mainte-
nance of the repressive state of transcription. EZH2 is known to be important for neurogenesis, controlling the 
renewal of progenitor cells in general and cerebellum development. Ezh2 conditional knock-out mice showed 
hypoplasia of the cerebellum and decreased numbers of Purkinje cells49, 50. Based on our analysis, EZH2 is 
involved in regulating NEUROD2 in the cerebellum and NPAS3 in the metencephalon, as well as SHANK1 and 
ZIC2 inside both the metencephalon and cerebellum among other neuron related genes. EZH2 is potentially 
involved in the development of ataxia-telangiectasia51. Mouse studies suggest that Zic2 is involved in cerebellar 
development, and mutations in Zic2 have been associated with sensorimotor gating abnormalities in mice52, 53. 
Related to sensorimotor gating abnormalities, SHANK1 deletions in humans have been proposed as a factor for 
autism spectrum disorder and in addition resulted in reduced motor functions in mice54, 55. A mouse study pro-
vides evidence for a role of NEUROD2 for cerebellar granule cell survival and development of ataxia56. NPAS3 has 
been identified as a risk factor for schizophrenia and bipolar disorder and inactivating mutations in NPAS1 and 
Figure 4. Examples of reoccurring RNA structure motifs. Each panel shows the consensus structure based on 
the predicted instances of the corresponding conserved RNA structure (CRS) motif and instances of the CRS in 
brain related genes. The sequence identity is computed over the predicted instances of the motif and given by a 
white to blue color gradient. RNA secondary structure diagrams were drawn with RNAfdl104.
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NPAS3 cause behavioral abnormalities in mice57, 58. Considering these studies, our results support the idea that 
abnormalities in EZH2 expression inside the cerebellum or metencephalon could be a contributing factor for the 
development of neurological disorders such as ataxia and autism spectrum disorder.
Based on our analysis, NR3C1 exhibits a localized contribution to gene expression in the cerebral cortex and is 
involved in the regulation of Ephrin A5 and CDK5R1. Supporting the role of NR3C1 in the cerebral cortex, NRC3 
is a known hypothalamic-pituitary-adrenal (HPA) axis gene and has a function in controlling brain response to 
stress. Epigenetic regulation of NR3C1 and decreased expression in the hippocampus, a sub-region of the limbic 
lobe inside the cerebral cortex, has been associated with victims of child abuse59, 60. The gradients of Ephrin-As 
expression including Ephrin A5 expression were shown to effect formation of the visual map inside the cortex61. 
Abnormal expression of NR3C1 in the cerebral cortex may have a relevance for neurological disorders given the 
predicted contribution to regulation of CDK5R1. The accumulation p25, a cleavage product of CDK5R1, has been 
found to be increased in the frontal cortex of Alzheimer’s patients62.
For SRF, we predicted localized contribution to gene expression in the basal forebrain where SRF is predicted 
to regulate F-box proteins among other genes. SRF is an important TF for angiogenesis and neurodevelopmental 
processes. It promotes filopodia formation and contributes to normal asymmetric growth of neuritis. Srf knock-
out mice die early in gastrulation due to the lack of mesenchymal tissue formation including heart. Srf activation 
is important for regulation of neuronal migration and axon and dendrite arboration in developing cortex and 
retina63. For a discussion of SRF regulated F-box proteins refer to supplementary text S1 - Extended discussion 
of TF regulated genes64–69. Although the exact function of SRF in the brain is not obvious from our analysis, our 
results may suggest that SRF also provides an important contribution to gene expression in adult brains.
In addition to analyzing TF-gene interactions, we derived RNA secondary structure motifs from enriched reg-
ulatory elements located in mRNAs that are differentially expressed between different neuroanatomical regions. 
Here, we identified a group of hairpin motifs that have purine-uracil-repeats ((RU)n-repeats) in common. RNA 
secondary structures comprising trinucleotide repeats are known to be relevant to certain neurological disor-
ders70. In our analysis, CRS motif M1260981 was predicted to overlap REs in five genes with neuron related 
functions, i.e., ACSL4, NDST1, PLXNA1, TSPAN2 and RAPH1. Mutations or deletions in ACSL4, also known 
as FACL4, have been previously linked to non-specific mental retardation71. Another motif from this group, CRS 
motif M2126347, was predicted in TET2 and TET3, among others genes. Tet2 activity is an important factor for 
epigenetic regulation during mouse brain development72. CRS motif M1146447, a motif lacking (RU)n-repeats, 
was predicted to overlap REs of ERLIN2, FKBP5 and SPHK2. ERLIN2 deletions or frame shift mutations have 
been implicated in spastic paraplegia and mental retardation, respectively73, 74. Predicted instances of M1260981 
in ACSL4 and RAPH1 overlap binding sites for RBM47 (Supplemenatry text S1 - Table S5). Note that we com-
puted an enrichment for structured binding sites for RBM47 in differentially expressed genes including these two 
transcripts. In contrast, NDST1, PLXNA1 and TSPAN2 are part of sets of differentially expressed transcripts that 
were enriched for RBP binding sites in general, but not for a specific protein. However, instances of M1260981 in 
NDST1, PLXNA1, TSPAN2 overlap binding sites for IGF2BP3, SRRM4 and MSI1, respectively. Instances of CRS 
motif M1146447 in FKBP5 overlap binding sites for RBM47 and in ERLIN2 and SPHK2 overlap binding sites for 
IGF2BP3. RBM47 as well as IGF2BP3, SRRM4 and MSI1 contain RNA recognition motifs (RRM). Specifically in 
the context of RRMs, RNA secondary structures have been suggested to enhance the affinity for RBP binding, for 
instance, by restricting the conformational flexibility of loop regions that contain binding motifs75. The double 
stranded-regions of the identified stem loops could also serve directly as binding motifs for RBPs. Another possi-
bility is that the transient formation of the predicted RNA structures decreases the accessibility of single-stranded 
motifs. For more elaborate information on the identified CRS motifs refer to ‘Supplementary text S1 - Instances of 
RNA secondary structure motifs’ and ‘Supplementary text S1 - Extended discussion of RNA secondary structure 
motifs’. Recruited RBPs can alter the expression of a transcript in several ways. RBM47 has been suggested to be a 
mediator for RNA editing76 and to be involved in mRNA stability and splicing77. Differential splicing of 3′ UTRs 
may shorten the UTR length, thus increase the stability of a transcript, e.g. through removal of miRNA binding 
sites78. While we can only speculate about exact mechanisms, the predicted structures pose interesting candidates 
for potential regulatory motifs in mRNAs with relevance for CNS related processes. Further investigation of the 
predicted RNA secondary structure motifs is necessary to elucidate their function.
In closing, we discuss some technical aspects regarding our analysis. We designed a regression approach that 
focused on the most robust transcription factor interactions. As discussed in the introduction, methods that 
directly infer read counts or are based on TF perturbation experiments were not applicable to our study12, 13, 18, 79. 
Instead, we identified TF-gene interactions by a four step filtering process. First, we limited potential TF-gene 
interactions to top scoring ChIP-seq binding sites14–17. Second, we applied LASSO regression to model the expres-
sion of a gene as sparse linear combination of the expression of potentially interacting TFs. The LASSO penalty 
induces sparsity19, i.e., LASSO removes TFs that do not add strongly relevant information to the models. Third, 
we compared regression models to random models, discarding ones that did not significantly outperform ran-
dom ones. A disadvantage of this third step is the randomization procedure. Random selection of training/test 
sets and also random gene-gene interactions both limit the reproducibility of the analysis. Therefore, in a fourth 
step, we only considered TF-gene interactions that were part of the linear models in five independent instances 
of the analysis. We initialized each instance of the analysis with different unique random seeds. Experimental 
factors also limit our analysis, particularly the availability of suitable ChIP-seq data from which to infer potential 
TF-gene interactions, as well as the post-mortem nature of the six donated brain samples10. We modeled gene 
expression based on 141 TFs that were present in the analyzed micro arrays and available from the UCSC genome 
browser’s ENCODE ChIP-seq tracks17. Consequently, this analysis may underestimate regulation by TFs, given 
the current estimate of ≈1500 of human TF genes80. Sunkin et al. performed a thorough quality assessment and 
took proper precautions for handling post-mortem tissue and data normalization when generating the data for 
the Allen Brain Atlas10. However, post-mortem RNA expression likely exhibits deviations from gene expression 
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of functional adult brains, e.g., reduced expression of some transcripts81. Although we focused on robust findings 
in our analysis and found causal associations with brain related functions, we cannot rule out the influence of 
post-mortem processes on gene expression. We also would like to point out that we analyzed brain tissues of adult 
donors with the aim to study differences between anatomical brain regions. Consequently, insights into gene 
regulatory processes that drive brain tissue development are out of scope for this analysis. Similarly, the analyzed 
microarray data provides a snapshot of the gene expression levels. Hence, the oscillatory nature of transcriptional 
processes or transcriptional delay in general cannot be considered in this study82–84. Different studies argue in 
favor and against a high correlation between mRNA expression and protein expression levels85–87. Given a less 
comprehensive data set, it would be interesting to compare the results of our current models with models for 
which we replace TF mRNA expression levels with TF protein expression levels or ChIP-seq data.
For the second part of our study, we only focused on RNA secondary structure motifs with well conserved 
base pairs. We inferred conserved secondary structure predictions from a genome-wide screen using CMfinder 
filtered by pscore which considers phylogenetic conservation31, 88, 89. Subsequently, we compared the parsimony 
of present and absent base pairs using evolutionary subtrees containing 11 and 26 species based on 100-way 
genome-wide alignments, i.e., closely related primates and rodents, respectively17, 90. CMfinder re-aligns the input 
sequence alignments during structure prediction88. This has the advantage that our predictions are less dependent 
on the quality of the input alignment. We used a parsimony criterion to compare a list of candidates where we 
only considered structures that were predicted for approximately the same set of species. Hence, this allows us to 
circumvent issues associated with computing a background model or estimating mutation rates for the parsimony 
analysis. The separate parsimony analysis also allows us to define specific evolutionary constraints. In addition, 
we selected only sequences for which 90% of the base pairs of the consensus structure were conserved. Similarly 
to the ChIP-seq data in the first part of this analysis, the set of RBP binding sites we used was derived from 
CLIP-seq experiments probing specific regions or cell lines, thus they indicate potential binding sites, but give no 
evidence for or against functional interactions in the brain. From our analysis, it is not directly possible to deduce 
whether there is a functional relationship between the predicted RNA secondary structures and specific types of 
regulatory elements. The contribution of the predicted RNA secondary structures to gene expression has to be 
proved experimentally, for instance by knockout experiments. Nonetheless, we identified promising candidate 
CRS motifs that may have functional implication for gene expression in brain regions.
Conclusion
We identified TF-gene interactions and RNA secondary structure motifs in mRNAs that facilitate potentially 
important functions in the CNS and could be relevant to the etiology of neurological disorders. In particu-
lar, RNA secondary structure motifs identified in ERLIN1, ACSL4, TET2 and TET3, as well as the localized 
contribution of EZH2 to the regulation of ZIC2 and SHANK1 in the cerebellum are promising candidate for 
future investigation. Experiments such as protein-binding assays, RNA structure probing and mutation studies, 
immuno-precipitation approaches or knockout studies could help to elucidate the underlying processes and to 
verify functional implications.
Methods
Data sets. Allen Human Brain Atlas. Whole-genome micro array data of post-mortem human brain region 
was downloaded from the Allen Brain Atlas for six human donors10. See Supplementary file S1: Micro array data 
sets, page 3–5, for a more elaborate description of the data set. We only used micro array data instead of RNA-seq 
data as the whole brain micro array data is available for six donors, but the RNA-seq data only for two donors. 
Hence, the RNA-seq data would provide less robust statistics. The micro array data is log-normalized and con-
tains present-call information. The data set contains between ≈300–890 samples for each of the donors covering 
all anatomical structures inside the brain. The data set contains samples for the left brain hemisphere for all 
donors and both brain hemispheres for left-handed donors. To reduce the bias of samples originating from differ-
ent human donors, only samples of left brain hemispheres were selected. When analyzing specific brain regions, 
we combined all samples of all brain sub-regions of the corresponding region using the ontology as specified by 
the Allen Brain Atlas. For robustness, we limited the analysis to brain regions that contain at least 20 samples 
summed up over all donors after collapsing replicates separately for each donor. This yields test sets that contain 
two or more samples for a 10-fold cross-validation that is performed as part of the analysis of transcription factor 
interactions.
Transcription factor interactions. Transcription factor (TF) binding site predictions were obtained from the 
UCSC Genome Browser ENCODE ChIP-seq track14–17. HGNC gene symbols of transcription factors were 
mapped to Entrez GeneID using ENSEMBL Biomart91. In the following, we describe how we obtained TF-gene 
interaction pairs. The UCSC ENCODE ChIP-seq track contains scores for clusters of binding sites for each TF. 
We converted these scores into Z-scores for each TF separately and selected only TF binding site predictions that 
achieved a Z-score of at least 1.96. If a TF binding site was within ±10,000 nucleotides distance to the transcrip-
tion start site (TSS) of a gene we assigned a TF-target gene pair. This corresponds to interactions up- and down-
stream of the TSS that are assumed to have a moderate effect on the target gene expression92. The resulting set of 
TF-target gene pairs contains 256,852 interactions between 141 TFs and 14,309 genes that overlap with Entrez 
gene IDs from the analyzed micro array data.
Conserved RNA secondary structure predictions. Conserved RNA secondary structures (CRSs) were inferred 
from a genome-wide screen for conserved RNA secondary structures31. To briefly summarize the methods of the 
screen, RNA secondary structures were predicted using CMfinder with a maximum base pair span for a single 
stem loop of 100 nt, and otherwise default parameters and pscore ≥5088, 89. CMfinder generates a covariance 
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model (CM), a probabilistic representation of the structure and evolutionary information, for each predicted CRS. 
Initial CRS predictions were performed by Seemann et al. using sequences from the 17-way MULTIZ alignment 
(MA) blocks93. The structural alignments were then extended by searching their CMs in orthologous sequences 
in each of the 100 vertebrate genomes in UCSC’s 100-species alignment using the Infernal framework17, 31, 40.
AURA. Regulatory elements (REs) were obtained from the AURA database30. The AURA database contains a 
collection of RNA protein binding sites from various CLIP-seq and similar data sets, validated miRNA target sites 
from miRecords and mirTarbase, AU-rich elements from the AREsite database and REs from literature mining 
and additional sources94–97. Since AURA only provides UTR specific coordinates for REs, we limited the analysis 
to REs in UTRs that mapped directly to genomic coordinates, e.g., we excluded spliced UTRs. The UCSC IDs 
of corresponding genes as provided by AURA were mapped to EntrezGeneIDs using Biomart91. In addition, we 
computed the overlap of REs provided by AURA and the predicted RNA secondary structures (see above) based 
on their genomic coordinates.
Regression analysis of transcription factor-gene interactions. A regression analysis was performed 
for evaluating TF-gene interactions inside each brain region separately (Supplementary file S1, Fig. S3). Only 
probes were considered for which at least 50% of the samples had a present call. We collapsed replicated sam-
ples by their median expression values and then collapsed probes that referred to the same EntrezGeneID by 
the median of expression value since we do not pool variances and replicated samples or probes may affect the 
weights of coefficients. In addition, we performed a cross-validation (CV). Replicates could compromise the 
validity of the CV.
We modeled the regulation by TFs of a gene g as the following regression problem, i.e., the expression of a gene 
g is modeled as a linear combination of the expression of transcription factors that target gene g:
β ε= +y X (1)g tf
where yg is a (nd × 1)-vector that contains the expression of gene g. nd is the number of samples and Xtf is an 
(nd × ntf)-matrix that contains the expression of each TF that is predicted to interact with target gene g (see Data 
sets: Transcription factor interactions). ntf is the number of TFs that are predicted to interact with gene g. β and 
ε refer to the coefficients to be determined and residuals, respectively. The sum of squared errors (SSE) of the fit, 
also known as residual sum of squares (RSS), is then defined as:
ε β β= = − −y X y XSSE ( ) ( ) (2)l g tf g tf
2
2
… l2 refers to the l2-norm. Regression analysis computes a fit, i.e., the coefficients β, to minimize the SSE. For each brain region, we first performed a least absolute shrinkage and selection operator (LASSO) regression using 
the glmnet R package19, 98. LASSO regression introduces sparsity, i.e., a subset of the coefficients β are set to zero, 
by adding a l1-norm regularization term to the minimization problem. The following minimization problem is 


















… l1 refers to the l1-norm. The regularization parameter λ was determined using the ‘cv.glmnet’ procedure of the glmnet R package with the one-standard-error-rule. Next, we selected only TFs with non-zero coefficients and at 
most nd − 1 coefficients. The Xtf matrix was then reduced to the expression data of the selected TFs and we per-
formed a 10-fold cross validation (CV) for fitting a linear model using the R function ‘lm’. For each fold of the CV, 
we computed the SSE for the fit. Since LASSO regression requires at least two parameters no LASSO regression 
was performed in advance if fewer than two TFs were predicted to target a gene g. For evaluating the regression 
models, we generated ten random models for each gene where we picked ntf random genes instead of the TFs 
predicted to target the gene and performed the same procedure including LASSO regression as mentioned above. 
We defined that a gene was regulated by TFs if the average SSE was significantly lower than the average SSE of the 
random models. To evaluate whether the average SSE was significantly lower than the one of random models, we 
performed one-sided t-tests where we compared the 10 SSEs of the original models with the 100 SSEs of the ran-
dom models. Here, the null hypothesis is that the SSEs between the TF-interaction based models and random 
models follows the same distribution. The alternative hypothesis is that the SSEs are smaller than the ones of 
random models. The resulting p-values were adjusted over all genes using the ‘p.adjust’ R function with a 
Benjamini-Hochberg correction99. We considered an adjusted p-value of 0.05 significant. In the following, only 
significant TF-gene interactions are used.
For evaluating the influence of each TF towards the expression of a predicted target gene, we computed the rel-
ative contribution of each TF to a target gene based on the computed LASSO coefficients. Here, we first compute 













Here, βtf is the LASSO coefficient of a single TF, xtf,i and yg,i refer to the expression of the TF and target gene of 
sample i, respectively. The TF contribution ctf,g for a gene g expressed inside a region is then defined as the mean 
value over the set of samples D:
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The overall contribution of a TF tf for a region is given by the absolute sum over the contributions to all genes g:
∑=s c (6)tf g tf g,
We ranked all TFs by their absolute sum of relative contributions stf inside each region separately. To identify TFs 
that exhibit high or low localized contributions to gene expression, we calculated Shannon entropy over all 
regions inside the same brain region ontology coarse-graining level which we refer to as depth. Our approach 
essentially follows the definition for region specific gene expression by Schug et al.20. We define the relative fre-












where T refers to the set of regions, stf,k and stf,j refer to the absolute sum of contributions of the TF for region k and 
region j, respectively. Consequently, the Shannon entropy for the contribution of a TF tf is given by:
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A low entropy indicates a TF with stronger local contributions to one or a few regions while high entropies indi-
cate more evenly distributed contributions over the regions.
Two steps during this procedure involve randomization, i.e., choosing the λ value during LASSO regression 
and the comparison of linear models to random models. To consider random artifacts and the reproducibility of 
our results, we defined a list of 500 unique random numbers and repeated the same analysis five times. Here, we 
used each time and for each region a different random number from the list of random numbers for initializing 
the random number generator.
Differential expression analysis. We computed the pair-wise differential expression between all 
sub-regions of a specified brain region (Supplementary file S1, Fig. S1). This was done from a brain region ontol-
ogy depth 2 down to a brain region ontology depth 6. In total, this includes nine different brain regions and 
pair-wise comparisons between two to five corresponding sub-regions (Supplementary file S1, Table S4). For 
the differential expression analysis, only probes were considered for which at least 50% of the samples of at least 
one of the sub-region had a present call. Considering the post-mortem nature of the heterogeneous regions and 
expected noise, pair-wise differential expression analysis was performed using limma with a fold-change thresh-
old of log2 1.539. As recommended by the limma user-guide, the TREAT procedure with fold-change threshold 
was used100. Afterwards, ‘decideTests’ was used for the selection of significantly differentially expressed genes. The 
null hypothesis in this case is that the difference in mean expression between two regions is within a fold-change 
threshold of log2 1.5. Benjamini-Hochberg corrections for multiple testing was applied to each contrast sepa-
rately99, but samples of all sub-regions of an analyzed brain region were used as input at once. A design matrix 
was defined in such a way that all samples of the same sub-region were assigned to the same source. In contrast 
to the regression analysis, we did not collapse replicates since procedures such as limma fit a linear model for 
pooling variances, thus replicates are already considered and provide additional information. All genes that were 
differentially expressed between any two sub-regions were collected as the set of differentially expressed genes for 
a specific brain region. In addition, based on significant up- and down-regulation over all contrasts, we identified 
probes that had a significantly higher or lower expression inside one sub-region compared to all sub-regions. We 
refer to such genes as genes with localized expression in a specific brain region.
Enrichment analysis of regulatory elements. For analyzing the enrichment between REs and differ-
entially expressed genes, we defined the set of all protein-coding genes by ENSEMBL transcripts that could be 
mapped to EntrezGeneIDs91, 101. Chi-square test were then used to evaluate the association between differentially 
expressed genes and genes that contain REs inside their UTRs (Supplementary file S1, Fig. S2). For this purpose, 
the R function ‘chisq.test’ was used. The R function ‘chisq.test’ estimates p-values through a Monte Carlo approx-
imation. We used 108 replicates for the Monte Carlo approximation as this number of replicates provided stable 
p-values up to the third decimal place. Here, we only considered REs that were present in the UTRs of at least ten 
differentially expressed genes and ten genes that were not differentially expressed to ensure a relevant approxima-
tion of p-values. We distinguished between RE types such as AU-rich elements (ARE) or RNA binding proteins 
(RBP) and specific RE elements such as ELAVL1 bindings sites or miR-96 target sites. For each region separately, 
we performed Chi-square tests for REs and structured REs (see above). We then performed Benjamini-Hochberg 
corrections for multiple-testing separately for RE types and RE elements for each region using the R function 
‘p.adjust’99. An adjusted p-value of 0.05 was considered significant.
Analysis of RNA secondary structure motifs. Conserved phylogenetic subtrees and filtering. For assess-
ing the quality of a predicted RNA secondary structure, we inspected evolutionary conservation of the predicted 
structure. We developed an approach to identify the largest phylogenetic subtree with respect to the number of 
species inside a phylogenetic tree of 100 vertebrate species for which the structure motif was predicted for at least 
80% of the species. For the structure predictions31 (see Data sets: Conserved RNA secondary structure 
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predictions), we computed fingerprints (FP) that indicate presence and absence of base pairs of the consensus 
structure by projecting the consensus structure to the individual sequences. A base pair is absent if the projection 
resulted in non-canonical base pairs or included gaps. Leafs in a phylogenetic tree are annotated with the corre-
sponding fingerprints for each species. Next, we identified the largest phylogenetic subtree where the FP of each 
leaf had a dissimilarity to the human FP smaller than a defined threshold θ = .0 2dh . Therefore, we computed 
Hamming distances h between FPs and calculated a ratio =dh
h
nbp
 where nbp is the number of base pairs of the 
consensus structure. The largest phylogenetic sub-tree is identified by iteratively processing the subtree of the next 
common ancestor of human. Note that we used the 100 vertebrate phylogenetic tree given as New Hampshire 
(NH) standard, i.e., in Newick tree format, from the UCSC genome browser where all ancestor nodes are internal 
nodes and not assigned to a specific species17. For each iteration, the fraction of species that contains a FP with a 
sufficient similarity to the human FP is evaluated. In this way, we identified the largest phylogenetic subtree in 
which the predicted structure motif is conserved for at least 80% of the species. We computed the average pair-wise 
sequence identity and the GC content over the sequences of the resulting phylogenetic subtree. To compute the 
average pair-wise sequence identity, we counted identities between non-gap characters of each two sequences 
normalized by the gap-free length of the shorter sequence and computed the average of all pair-wise comparisons. 
For the selection of reoccurring motifs, only motifs with a sequence identity lower than 95% and a GC content, cgc, 
in a range 0.2 < cgc < 0.8 were considered. Sequences that overlapped non-simple repeats annotated in the UCSC 
GenomeBrowser rmask track (hg38) by RepeatMasker were removed from this part of the analysis (Smit, AFA, 
Hubley, R and Green, P. RepeatMasker Open-4.0. 2013–2015, http://www.repeatmasker.org)17, 102, 103.
Parsimony computation. To select evolutionarily well conserved candidate structures, we calculated parsimony 
scores inside different subtrees for the base pair fingerprints (FP). Parsimony scores indicate the minimum num-
ber of necessary relabeling operations for each base pair given the phylogenetic tree. Different subtrees were 
defined based on branch lengths in the phylogenetic tree that we obtain from the UCSC genome browser17. We 
defined five subtrees that comprise i) the 11 most closely related primates T11, ii) 26 primates and rodents T26, iii) 
the 51 most closely related mammals T51, iv) 62 mammals T62 and v) 82 mammals, lizards and birds T82 
(Supplementary file S1, Fig. S1). Parsimony scores were calculated in a bottom-up manner as specified by the 
Fitch algorithm90. In case of a missing sequence for a species, i.e., when CMsearch did not return a hit for the 
corresponding sequence of the species, no penalty was added, but we limited the parsimony computation to RNA 
secondary structures motifs that were predicted for 80% of the species inside the analyzed subtree (see last sec-
tion). The parsimony score was then weighted by the sequence length and the number of species. For FPs the 
alphabet is = {0, 1}  where 0 indicates the absence and 1 the presence of the base pair. Motifs were selected that 
exhibited a FP based parsimony score lower than the median parsimony score of all RNA secondary structure 
motifs for both subtree T11 and subtree T26.
Structure motifs reoccurrence. From the structural alignment of each CRS that overlapped annotated enriched 
regulatory elements (structured REs) in differentially expressed genes, we extracted the human sequence and 
extended it 25 nt upstream and 25 nt downstream of the predicted structure. CMsearch was then used to identify 
significantly similar motifs in all human sequences containing enriched structured REs, i.e., CMsearch hits with 
a significant E-value indicated by a exclamation mark in the output40. The covariance models (CM) of the RNA 
secondary structure motifs were calibrated on the 17-way structural alignments that were used for the initial 
predictions. For predicted instances of a motif, we verified that 80% of the base pairs of the consensus structure 
could be successfully projected to the matched sequence, as mentioned above. From this set, we selected instances 
of the motifs that were found in enriched structured REs of genes which were differentially expressed in a given 
brain region, for each region separately.
GO-term enrichment analysis. GO-term enrichment for genes was computed using the 
over-representation analysis feature of the ConsensusPathDB web server (release 31) with default param-
eters32. For differentially expressed genes, we defined the background as all genes that were part of the ana-
lyzed micro arrays and annotated with EntrezGeneIDs. The ConsensusPathDB computes enrichment through 
a hyper-geometric test and applies a false discovery rate (FDR) correction. GO terms with a q-value < 0.05 were 
considered significant for this study.
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